Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.40    -9.00 (-2.68%)
Bid:
326.60
Ask:
327.40
Spread: 0.80 (0.245%)
Market Cap: £715.04m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Trading Update

3 Jul 2014 07:00

RNS Number : 2876L
Burford Capital
03 July 2014
 



3 July 2014

BURFORD CAPITAL CONTINUES STRONG PERFORMANCE

 

Investment returns rise to 63% on invested capital

 

Burford Capital Limited ("Burford"), the world's largest provider of investment capital and risk solutions for litigation, intends to release its interim financial statements for the six months ended 30 June 2014 on 4 September 2014.

 

In advance of that release, Burford provides the following performance update for the six month period ended 30 June 2014 (the "period"):

 

· Continued strong investment returns: Since inception, 26 investments have generated $173.9 million in gross investment recoveries and $67 million net of invested capital, producing a 63% net return on invested capital1

 

o This represents a 67% increase, $27 million, over the net position at 30 June 2013

 

· Material increase in cash generation: Burford generated $41.9 million of cash from the investment portfolio in the period, an increase of 94% over the comparable 2013 period

 

· Ongoing demand for Burford's capital reflected in $62 million of new capital committed in the period, a five-fold increase over the comparable 2013 period

 

· Successful completion of an innovative financing transaction with Rurelec PLC, a publicly-traded power generation company, that provided recourse financing linked to an arbitration claim, which provided an $11 million profit to Burford (a 73% return and a 34% IRR) while providing Rurelec with expansion capital

 

Christopher Bogart, Burford's CEO, commented: "Burford's performance continues to vindicate our approach to investment selection and the quality of our team. Moreover, the volume of new commitments made during the last six months shows clearly the market demand for litigation finance solutions - and the success of the Rurelec transaction we announced last month shows our continued market leadership in innovating to meet that demand."

 

1 Term definitions and computation methodology are as set forth in Burford's 2013 annual report.

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

John Llewellyn-Lloyd +44 (0)20 7456 9191

Harry Stockdale

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0)20 7653 4000

 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 3727 1046

Laura Ewart +44 (0)20 3727 1160

 

About Burford Capital

 

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

 

For more information about Burford, visit www.burfordcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAKXAEDFLEFF
Date   Source Headline
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company
28th Jun 202412:00 pmRNSIssue of New Shares for LTIP & Adjusted PDMR LTIP
21st Jun 20241:00 pmRNSIssue of New Shares Pursuant to DCP & PDMR Notices
6th Jun 20241:30 pmRNSPartial Repurchase and Cancellation of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.